PRLD
Prelude Therapeutics Inc
Company overview
- Market capitalization
- $312.03M
- Employees
- 79
- Latest publication
- 2026-09-29
About Prelude Therapeutics Inc
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms, myelofibrosis (MF), polycythemia vera, and essential thrombocythemia (ET); KAT6A for the treatment of advanced breast cancer and other solid tumors; and mutated calreticulin degrader antibody conjugates to treat MF and ET. The company has collaboration with AbCellera Biologics to discover, develop, and commercialize novel degrader antibody conjugates. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,704,000USD | 4,580,000USD | 5,640,000USD | 6,500,000USD | 0USD | 0USD | 4,000,000USD | 3,000,000USD |
| Research Development | 16,131,000USD | 13,601,000USD | 17,992,000USD | 21,708,000USD | 25,784,000USD | 28,816,000USD | 31,620,000USD | 29,457,000USD |
| Selling General Administrative | 5,027,000USD | 5,156,000USD | 4,996,000USD | 5,210,000USD | 6,410,000USD | 5,790,000USD | 6,211,000USD | 7,919,000USD |
| General And Administrative Expenses | 5,027,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 21,158,000USD | 18,366,000USD | 22,988,000USD | 26,918,000USD | 32,194,000USD | 34,606,000USD | 37,831,000USD | 37,376,000USD |
| Operating Income | -15,454,000USD | -14,177,000USD | -17,348,000USD | -20,418,000USD | -32,194,000USD | -34,606,000USD | -33,831,000USD | -34,376,000USD |
| Total Other Income Expense Net | 1,533,000USD | 3,792,000USD | 891,000USD | 693,000USD | 963,000USD | 2,521,000USD | 5,100,000USD | 2,105,000USD |
| Net Income | -13,921,000USD | -10,385,000USD | -16,457,000USD | -19,725,000USD | -31,231,000USD | -32,085,000USD | -28,731,000USD | -32,271,000USD |
| Cost Of Revenue | — | 391,000USD | 418,000USD | 425,000USD | 433,000USD | 435,000USD | 489,000USD | — |
| Gross Profit | — | 4,189,000USD | 5,640,000USD | 6,500,000USD | -433,000USD | -435,000USD | 4,000,000USD | 3,000,000USD |
| Selling And Marketing Expenses | — | 391,000USD | — | — | — | — | — | — |
| Income Before Tax | — | -10,385,000USD | -16,457,000USD | -19,725,000USD | -31,231,000USD | -32,085,000USD | -28,731,000USD | -32,271,000USD |
| Net Income From Continuing Ops | — | -10,385,000USD | -16,457,000USD | -19,725,000USD | -31,231,000USD | -32,085,000USD | -28,731,000USD | -32,271,000USD |
| Ebit | — | -14,177,000USD | -17,348,000USD | -20,418,000USD | -32,194,000USD | -34,606,000USD | -33,831,000USD | -34,376,000USD |
| Ebitda | — | -13,786,000USD | -16,930,000USD | -19,993,000USD | -31,761,000USD | -34,171,000USD | -33,342,000USD | -33,971,000USD |
| Depreciation And Amortization | — | 391,000USD | 418,000USD | 425,000USD | 433,000USD | 435,000USD | 489,000USD | 405,000USD |
| Reconciled Depreciation | — | 391,000USD | 418,000USD | 425,000USD | 433,000USD | 435,000USD | 489,000USD | 405,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12,140,000USD | 7,000,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 1,711,000USD | 1,772,000USD | 1,169,000USD | 3,042,000USD | 2,243,000USD | 542,000USD | 382,000USD | 149,000USD |
| Gross Profit | 10,429,000USD | 7,000,000USD | -1,169,000USD | -3,042,000USD | -2,243,000USD | -542,000USD | -382,000USD | -149,000USD |
| Research Development | 94,300,000USD | 117,995,000USD | 103,393,000USD | 92,889,000USD | 86,778,000USD | 48,177,000USD | 24,279,000USD | 12,621,000USD |
| Selling General Administrative | 22,406,000USD | 28,719,000USD | 28,884,000USD | 30,651,000USD | 26,957,000USD | 10,586,000USD | 3,830,000USD | 2,354,000USD |
| Unclassified Operating Expenses | -1,711,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 114,995,000USD | 146,714,000USD | 132,276,999USD | 123,540,000USD | 113,735,000USD | 58,763,000USD | 28,109,000USD | 14,975,000USD |
| Operating Income | -104,566,000USD | -139,714,000USD | -132,276,999USD | -123,540,000USD | -113,735,000USD | -58,763,000USD | -28,109,000USD | -14,975,000USD |
| Income Before Tax | -99,498,000USD | -127,173,000USD | -121,832,000USD | -115,438,000USD | -111,694,000USD | -56,929,000USD | -27,570,000USD | -14,680,000USD |
| Net Income | -99,498,000USD | -127,173,000USD | -121,832,000USD | -107,336,000USD | -110,779,000USD | -56,929,000USD | -27,570,000USD | -14,680,000USD |
| Net Income From Continuing Ops | -99,498,000USD | -127,173,000USD | -117,398,000USD | -115,438,000USD | -111,694,000USD | -56,929,000USD | -27,570,000USD | -14,680,000USD |
| Ebit | -104,566,000USD | -139,714,000USD | -132,276,999USD | -123,540,000USD | -113,735,000USD | -58,763,000USD | -28,109,000USD | -14,975,000USD |
| Ebitda | -102,855,000USD | -137,942,000USD | -131,108,000USD | -122,216,000USD | -112,820,000USD | -58,221,000USD | -27,727,000USD | -14,826,000USD |
| Depreciation And Amortization | 1,711,000USD | 1,772,000USD | 1,168,999USD | 1,324,000USD | 915,000USD | 542,000USD | 382,000USD | 149,000USD |
| Reconciled Depreciation | 1,711,000USD | 1,772,000USD | 1,200,000USD | 1,324,000USD | 915,000USD | 542,000USD | 382,000USD | 149,000USD |
| Total Other Income Expense Net | 5,068,000USD | 12,541,000USD | 10,444,999USD | 8,102,000USD | 2,041,000USD | 1,834,000USD | 539,000USD | 295,000USD |
| Selling And Marketing Expenses | — | — | 1,169,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | -1USD | -8,102,000USD | -915,000USD | 335,703USD | 210,140USD | 295,000USD |
| Interest Expense | — | — | — | 1,324,000USD | 2,041,000USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -115,438,000USD | -111,694,000USD | -56,929,000USD | -27,570,000USD | -14,680,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 189,363,000USD | 119,642,000USD | 141,315,000USD | 94,755,000USD | 114,918,000USD | 141,260,000USD | 175,515,000USD | 197,220,000USD |
| Cash And Equivalents | 26,329,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 151,757,000USD | 81,554,000USD | 103,214,000USD | 54,957,000USD | 73,216,000USD | 99,074,000USD | 133,614,000USD | 153,626,000USD |
| Short Term Investments | 125,428,000USD | 59,798,000USD | 67,958,000USD | 7,425,000USD | 47,464,000USD | 58,805,000USD | 121,140,000USD | 142,492,000USD |
| Total Current Assets | 154,898,000USD | 84,593,000USD | 105,692,000USD | 58,330,000USD | 76,876,000USD | 102,403,000USD | 135,895,000USD | 156,387,000USD |
| Other Current Assets | 3,141,000USD | 3,039,000USD | 2,478,000USD | 3,373,000USD | 3,660,000USD | 3,329,000USD | 2,281,000USD | 2,761,000USD |
| Total Liabilities | 55,630,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 38,042,000USD | 41,720,000USD | 52,994,000USD | 18,190,000USD | 20,908,000USD | 19,787,000USD | 25,641,000USD | 22,224,000USD |
| Other Current Liabilities | 7,983,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 2,717,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 133,733,000USD | 60,183,000USD | 68,637,000USD | 58,534,000USD | 75,838,000USD | 103,178,000USD | 131,459,000USD | 156,431,000USD |
| Total Equity Including Noncontrolling Interest | 133,733,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 25,248,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 30,786,000USD | 31,500,000USD | 32,278,000USD | 33,080,000USD | 33,888,000USD | 34,703,000USD | 35,466,000USD | 36,384,000USD |
| Accounts Payable | 2,032,000USD | 2,069,000USD | 3,983,000USD | 2,533,000USD | 4,962,000USD | 5,831,000USD | 7,732,000USD | 5,921,000USD |
| Short Term Debt | 2,779,000USD | 2,761,000USD | 2,744,000USD | 2,727,000USD | 2,711,000USD | 2,653,000USD | 2,700,000USD | 2,724,000USD |
| Retained Earnings | -707,367,000USD | -693,446,000USD | -683,061,000USD | -666,604,000USD | -646,879,000USD | -615,648,000USD | -583,563,000USD | -554,832,000USD |
| Accumulated Other Comprehensive Income | -227,000USD | -41,000USD | 8,000USD | 2,000USD | -1,000USD | 12,000USD | 35,000USD | 167,000USD |
| Total Liab | — | 59,459,000USD | 72,678,000USD | 36,221,000USD | 39,080,000USD | 38,082,000USD | 44,056,000USD | 40,789,000USD |
| Other Current Liab | — | 5,938,000USD | 12,533,000USD | 12,930,000USD | 13,235,000USD | 11,303,000USD | 15,209,000USD | 13,579,000USD |
| Common Stock | — | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Capital Stock | — | 6,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Cash | — | 21,756,000USD | 35,256,000USD | 47,532,000USD | 25,752,000USD | 40,269,000USD | 12,474,000USD | 11,134,000USD |
| Current Deferred Revenue | — | 30,952,000USD | 33,734,000USD | — | — | — | — | — |
| Net Debt | — | -4,035,000USD | -17,467,000USD | -29,678,000USD | -7,835,000USD | -22,349,000USD | 5,551,000USD | 7,002,000USD |
| Short Long Term Debt Total | — | 17,721,000USD | 17,789,000USD | 17,854,000USD | 17,917,000USD | 17,920,000USD | 18,025,000USD | 18,136,000USD |
| Property Plant Equipment Gross | — | 31,500,000USD | 39,207,000USD | 33,080,000USD | 33,888,000USD | 34,703,000USD | 40,724,000USD | 36,384,000USD |
| Common Stock Shares Outstanding | — | 82,519,981shares | 62,953,628shares | 76,132,337shares | 75,993,941shares | 75,986,281shares | 75,896,061shares | 75,855,949shares |
| Non Current Assets Total | — | 35,049,000USD | 35,623,000USD | 36,425,000USD | 38,042,000USD | 38,857,000USD | 39,620,000USD | 40,833,000USD |
| Non Current Liabilities Total | — | 17,739,000USD | 19,684,000USD | 18,030,999USD | 18,172,000USD | 18,295,000USD | 18,415,000USD | 18,565,000USD |
| Non Current Liabilities Other | — | 2,779,000USD | 2,841,000USD | 2,904,000USD | 2,966,000USD | 3,028,000USD | 3,090,000USD | 3,153,000USD |
| Non Currrent Assets Other | — | 3,549,000USD | 3,345,000USD | 110,000USD | 4,154,000USD | 4,154,000USD | 4,154,000USD | 4,449,000USD |
| Net Working Capital | — | 42,873,000USD | 52,698,000USD | 40,140,000USD | 55,968,000USD | 82,616,000USD | 110,254,000USD | 134,163,000USD |
| Unclassified Non Current Liabilities | — | 14,960,000USD | 16,843,000USD | 15,126,999USD | 15,206,000USD | 15,267,000USD | 15,325,000USD | 15,412,000USD |
| Unclassified Equity | — | 753,659,000USD | 751,679,000USD | 725,126,000USD | 722,708,000USD | 718,804,000USD | 714,977,000USD | 711,086,000USD |
| Unclassified Non Current Assets | — | — | — | 3,235,000USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 141,315,000USD | 175,515,000USD | 277,665,000USD | 220,500,000USD | 305,098,000USD | 223,590,000USD | 21,871,000USD | 16,406,000USD |
| Other Current Assets | 2,478,000USD | 2,281,000USD | 2,654,000USD | 2,652,000USD | 3,882,000USD | 2,500,000USD | 1,345,000USD | — |
| Total Liab | 72,678,000USD | 44,056,000USD | 40,575,000USD | 25,063,000USD | 19,201,000USD | 11,407,000USD | 71,283,000USD | 39,099,000USD |
| Total Stockholder Equity | 68,637,000USD | 131,459,000USD | 237,090,000USD | 195,437,000USD | 285,897,000USD | 212,183,000USD | -49,412,000USD | -22,693,000USD |
| Other Current Liab | 12,533,000USD | 15,209,000USD | 15,768,000USD | 13,093,000USD | 9,621,000USD | 7,455,000USD | 2,603,000USD | 1,085,000USD |
| Common Stock | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD | — | — |
| Capital Stock | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD | 0USD | 0USD |
| Retained Earnings | -683,061,000USD | -583,563,000USD | -456,390,000USD | -334,558,000USD | -219,120,000USD | -107,426,000USD | -50,497,000USD | -22,927,000USD |
| Cash | 35,256,000USD | 12,474,000USD | 25,291,000USD | 30,605,000USD | 31,828,000USD | 218,309,000USD | 18,879,000USD | 15,595,000USD |
| Cash And Short Term Investments | 103,214,000USD | 133,614,000USD | 232,935,000USD | 201,728,000USD | 291,233,000USD | 218,309,000USD | 18,879,000USD | 15,595,000USD |
| Total Current Assets | 105,692,000USD | 135,895,000USD | 235,589,000USD | 204,380,000USD | 295,115,000USD | 220,809,000USD | 20,224,000USD | 15,595,000USD |
| Total Current Liabilities | 52,994,000USD | 25,641,000USD | 21,829,000USD | 21,702,000USD | 19,201,000USD | 11,375,000USD | 4,835,000USD | 2,447,000USD |
| Current Deferred Revenue | 33,734,000USD | — | 14,823,000USD | — | — | — | — | — |
| Net Debt | -17,467,000USD | 5,551,000USD | -8,403,000USD | -28,773,000USD | -30,088,000USD | -218,309,000USD | -18,621,000USD | -15,595,000USD |
| Short Term Debt | 2,744,000USD | 2,700,000USD | 1,481,000USD | 1,832,000USD | 1,740,000USD | — | 258,000USD | — |
| Short Long Term Debt Total | 17,789,000USD | 18,025,000USD | 16,888,000USD | 1,832,000USD | 1,740,000USD | — | 258,000USD | — |
| Short Term Investments | 67,958,000USD | 121,140,000USD | 207,644,000USD | 171,123,000USD | 259,405,000USD | 0USD | — | — |
| Accounts Payable | 3,983,000USD | 7,732,000USD | 4,580,000USD | 6,777,000USD | 7,840,000USD | 3,920,000USD | 1,974,000USD | 1,362,000USD |
| Property Plant Equipment Net | 32,278,000USD | 35,466,000USD | 37,737,000USD | 6,700,000USD | 5,636,000USD | 2,480,000USD | 1,647,000USD | 811,000USD |
| Property Plant Equipment Gross | 39,207,000USD | 40,724,000USD | 41,303,000USD | 6,700,000USD | 5,636,000USD | 2,480,000USD | 1,647,000USD | 811,000USD |
| Accumulated Other Comprehensive Income | 8,000USD | 35,000USD | 223,000USD | -1,692,000USD | -711,000USD | -223,590,000USD | -556,000USD | -191,000USD |
| Common Stock Shares Outstanding | 76,956,194shares | 75,805,840shares | 60,357,052shares | 47,371,589shares | 47,602,336shares | 43,705,672shares | 32,401,826shares | 1,576,395shares |
| Non Current Assets Total | 35,623,000USD | 39,620,000USD | 42,076,000USD | 16,120,000USD | 9,983,000USD | 2,781,000USD | 1,647,000USD | 811,000USD |
| Non Current Liabilities Total | 19,684,000USD | 18,415,000USD | 18,746,000USD | 3,361,000USD | 9,580,000USD | 32,000USD | 66,448,000USD | 36,652,000USD |
| Non Current Liabilities Other | 2,841,000USD | 3,090,000USD | 3,339,000USD | 3,361,000USD | — | 32,000USD | 5,000USD | 57,000USD |
| Non Currrent Assets Other | 3,345,000USD | 4,154,000USD | 4,339,000USD | 9,420,000USD | 4,347,000USD | 301,000USD | — | — |
| Net Working Capital | 52,698,000USD | 110,254,000USD | 213,760,000USD | 182,678,000USD | 275,914,000USD | 209,434,000USD | 15,389,000USD | 13,148,000USD |
| Unclassified Non Current Liabilities | 16,843,000USD | 15,325,000USD | 15,407,000USD | -3,361,000USD | 9,580,000USD | — | 66,438,000USD | 36,538,000USD |
| Unclassified Equity | 751,679,000USD | 714,977,000USD | 693,247,000USD | 531,677,000USD | 505,718,000USD | 543,191,000USD | 1,641,000USD | — |
| Unclassified Current Liabilities | — | — | -14,823,000USD | — | — | — | — | — |
| Other Liab | — | — | — | 3,361,000USD | — | 32,000USD | 5,000USD | 57,000USD |
| Other Assets | — | — | — | 9,420,000USD | 4,347,000USD | 301,000USD | — | — |
| Net Tangible Assets | — | — | — | 195,437,000USD | 285,897,000USD | 212,183,000USD | -49,412,000USD | -22,693,000USD |
| Unclassified Non Current Assets | — | — | — | -9,420,000USD | -4,347,000USD | — | — | — |
| Deferred Long Term Liab | — | — | — | — | — | 301,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 744,000USD |
| Stock Based Compensation | 4,027,000USD |
| Change To Liabilities | -6,714,000USD |
| Change In Working Capital | -12,980,000USD |
| Operating Cash Flow | -37,259,000USD |
| Capital Expenditures | 0USD |
| Net Investments | -57,004,000USD |
| Investing Cash Flow | -57,004,000USD |
| Net Debt Issuance | 0USD |
| Common Stock Issuance | 115,000USD |
| Net Common Stock Issuance | -64,000USD |
| Unclassified Financing Cash Flow | 85,455,000USD |
| Financing Cash Flow | 85,506,000USD |
| Change In Cash | -8,757,000USD |
| End Cash Flow | 29,734,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,385,000USD | -16,457,000USD | -19,725,000USD | -31,231,000USD | -32,085,000USD | -28,731,000USD | -32,271,000USD | -34,740,000USD |
| Depreciation | 391,000USD | 285,000USD | 425,000USD | 433,000USD | 435,000USD | 489,000USD | -3,283,000USD | 452,000USD |
| Stock Based Compensation | 2,000,000USD | 1,844,000USD | 2,423,000USD | 3,814,000USD | 3,832,000USD | 3,774,000USD | 12,017,902USD | 6,098,000USD |
| Other Non Cash Items | 1,999,000USD | 329,000USD | 334,000USD | 170,000USD | 463,000USD | -563,000USD | -2,897,902USD | -935,000USD |
| Change In Working Capital | -13,690,000USD | 37,118,000USD | -2,572,000USD | 739,000USD | -6,876,000USD | 4,287,000USD | -862,000USD | 6,068,000USD |
| Total Cash From Operating Activities | -21,685,000USD | 23,119,000USD | -19,115,000USD | -26,075,000USD | -34,231,000USD | -20,744,000USD | -27,296,000USD | -23,057,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -20,000USD | -47,000USD | -53,000USD | -63,000USD | -359,000USD |
| Free Cash Flow | -21,685,000USD | 23,119,000USD | -19,115,000USD | -26,095,000USD | -34,278,000USD | -20,797,000USD | -27,359,000USD | -23,416,000USD |
| Investments | 8,499,000USD | -60,339,000USD | 40,091,000USD | 11,521,000USD | 62,186,000USD | 22,118,000USD | 10,733,000USD | 26,119,000USD |
| Total Cashflows From Investing Activities | 8,499,000USD | -60,339,000USD | 40,091,000USD | 11,521,000USD | 62,186,000USD | 22,118,000USD | 10,733,000USD | 26,119,000USD |
| Net Borrowings | 0USD | 0USD | 0USD | -53,000USD | -155,000USD | -151,000USD | -148,000USD | — |
| Total Cash From Financing Activities | -314,000USD | 24,944,000USD | -5,000USD | 37,000USD | -160,000USD | -34,000USD | -131,000USD | 59,000USD |
| Change In Cash | -13,500,000USD | -12,276,000USD | 20,971,000USD | -14,517,000USD | 27,795,000USD | 1,340,000USD | -16,694,000USD | 3,121,000USD |
| Begin Period Cash Flow | 35,256,000USD | 50,767,000USD | 29,796,000USD | 44,313,000USD | 16,518,000USD | 15,178,000USD | 31,872,000USD | 28,751,000USD |
| End Period Cash Flow | 21,756,000USD | 38,491,000USD | 50,767,000USD | 29,796,000USD | 44,313,000USD | 16,518,000USD | 15,178,000USD | 31,872,000USD |
| Other Cashflows From Financing Activities | -51,000USD | -5,000USD | -5,000USD | -2,000USD | -5,000USD | -7,000USD | -13,000USD | 155,000USD |
| Unclassified Operating Cash Flow | -2,000,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 24,949,000USD | — | — | — | — | — | — |
| Sale Purchase Of Stock | — | — | 5,000USD | — | -5,000USD | — | 34USD | -18USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 26,478USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -99,498,000USD | -127,173,000USD | -121,832,000USD | -115,438,000USD | -111,694,000USD | -56,929,000USD | -27,570,000USD | -14,680,000USD |
| Depreciation | 1,340,000USD | 1,772,000USD | 1,169,000USD | 1,324,000USD | 915,000USD | 542,000USD | 382,000USD | 149,000USD |
| Stock Based Compensation | 11,913,000USD | 21,345,000USD | 25,616,000USD | 25,144,000USD | 20,931,000USD | 5,583,000USD | 846,000USD | 180,000USD |
| Other Non Cash Items | 1,534,000USD | -3,048,000USD | -1,537,000USD | 4,309,000USD | 2,692,000USD | 11,000USD | 10,000USD | 15,000USD |
| Change In Working Capital | 28,409,000USD | 4,216,000USD | -10,479,000USD | 932,000USD | 3,625,000USD | 4,616,000USD | 667,000USD | 1,382,000USD |
| Total Cash From Operating Activities | -56,302,000USD | -102,888,000USD | -107,063,000USD | -83,729,000USD | -83,531,000USD | -46,177,000USD | -25,665,000USD | -12,954,000USD |
| Capital Expenditures | -67,000USD | -764,000USD | -3,513,000USD | -3,019,000USD | -2,323,000USD | -621,000USD | -780,000USD | -529,000USD |
| Free Cash Flow | -56,369,000USD | -103,652,000USD | -110,576,000USD | -86,748,000USD | -85,854,000USD | -46,798,000USD | -26,445,000USD | -13,483,000USD |
| Investments | 53,526,000USD | 90,191,000USD | -41,027,000USD | 81,691,000USD | -263,803,000USD | -621,000USD | -780,000USD | -529,000USD |
| Total Cashflows From Investing Activities | 53,459,000USD | 90,191,000USD | -34,646,000USD | 81,691,000USD | -263,803,000USD | -621,000USD | -780,000USD | -529,000USD |
| Net Borrowings | -208,000USD | -395,000USD | 0USD | — | 0USD | -258,000USD | -124,000USD | -124,000USD |
| Total Cash From Financing Activities | 24,816,000USD | -120,000USD | 136,395,000USD | 815,000USD | 164,897,000USD | 246,228,000USD | 29,729,000USD | 17,937,000USD |
| Issuance Of Capital Stock | 24,875,000USD | 0USD | 110,795,000USD | 110,691,000USD | 161,424,000USD | 246,398,000USD | 29,848,000USD | 17,937,000USD |
| Change In Cash | 21,973,000USD | -12,817,000USD | -5,314,000USD | -1,223,000USD | -182,437,000USD | 199,430,000USD | 3,284,000USD | 4,454,000USD |
| Begin Period Cash Flow | 16,518,000USD | 29,335,000USD | 34,649,000USD | 35,872,000USD | 218,309,000USD | 18,879,000USD | 15,595,000USD | 11,141,000USD |
| End Period Cash Flow | 38,491,000USD | 16,518,000USD | 29,335,000USD | 34,649,000USD | 35,872,000USD | 218,309,000USD | 18,879,000USD | 15,595,000USD |
| Other Cashflows From Financing Activities | -17,000USD | -54,000USD | 664,000USD | 815,000USD | 3,473,000USD | 79,856,000USD | 29,853,000USD | 17,937,000USD |
| Sale Purchase Of Stock | — | — | -17USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | 9,894,000USD | 2,934,290USD | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 135,731,017USD | -110,691,000USD | — | -79,768,000USD | -29,848,000USD | -17,813,000USD |
| Change To Liabilities | — | — | — | -347,000USD | 3,903,000USD | 1,157,000USD | 546,000USD | 721,000USD |
| Other Cashflows From Investing Activities | — | — | — | 84,710USD | -261,480USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.